NCT07196111

Evaluation of the Safety and Efficacy of BAFFR CAR-T Therapy in Clinical Studies for Recurrent/Refractory B Cell Tumors.

Study Summary

This study is a single-arm, multicenter clinical trial of dose escalation and dose expansion.

Interested in this trial?

Submit an Inquiry

Interventions

BAFFR CAR-TBIOLOGICAL
A single infusion of BAFFR CAR-T Injection administered intravenously.

Study Locations

No locations listed.

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: May 29, 2026